These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

387 related articles for article (PubMed ID: 29725805)

  • 1. Oncological safety and quality of life in men undergoing simultaneous transurethral resection of bladder tumor and prostate: results from a randomized controlled trial.
    Dellabella M; Branchi A; Gasparri L; Claudini R; Castellani D
    World J Urol; 2018 Oct; 36(10):1629-1634. PubMed ID: 29725805
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Simultaneous transurethral resection of bladder tumor and benign prostatic hyperplasia: hazardous or a safe timesaver?
    Tsivian A; Shtricker A; Sidi AA
    J Urol; 2003 Dec; 170(6 Pt 1):2241-3. PubMed ID: 14634388
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tumor recurrence in prostatic urethra following simultaneous resection of bladder tumor and prostate: a comparative retrospective study.
    Jaidane M; Bouicha T; Slama A; Hmida W; Hidoussi A; Ben Sorba N; Mosbah F
    Urology; 2010 Jun; 75(6):1392-5. PubMed ID: 19781747
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Feasibility of holmium laser enucleation of the prostate (HoLEP) for recurrent/residual benign prostatic hyperplasia (BPH).
    Elshal AM; Elmansy HM; Elhilali MM
    BJU Int; 2012 Dec; 110(11 Pt C):E845-50. PubMed ID: 22702908
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A prospective randomized study comparing bipolar plasmakinetic transurethral resection of the prostate and monopolar transurethral resection of the prostate for the treatment of Benign Prostatic Hyperplasia: efficacy, sexual function, Quality of Life, and complications.
    Otaola-Arca H; Álvarez-Ardura M; Molina-Escudero R; Fernández MI; Páez-Borda Á
    Int Braz J Urol; 2021; 47(1):131-144. PubMed ID: 33047918
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Assessment of the clinical efficacy of simultaneous transurethral resection of both bladder cancer and the prostate: a systematic review and meta-analysis.
    Zhou L; Liang X; Zhang K
    Aging Male; 2020 Dec; 23(5):1182-1193. PubMed ID: 32020826
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A randomized trial comparing holmium laser enucleation of the prostate with transurethral resection of the prostate for the treatment of bladder outlet obstruction secondary to benign prostatic hyperplasia in large glands (40 to 200 grams).
    Tan AH; Gilling PJ; Kennett KM; Frampton C; Westenberg AM; Fraundorfer MR
    J Urol; 2003 Oct; 170(4 Pt 1):1270-4. PubMed ID: 14501739
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Is it oncologically safe performing simultaneous transurethral resection of the bladder and prostate? A meta-analysis on 1,234 patients.
    Picozzi SC; Ricci C; Gaeta M; Casellato S; Bozzini G; Ratti D; Carmignani L
    Int Urol Nephrol; 2012 Oct; 44(5):1325-33. PubMed ID: 22710969
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Randomized study of transurethral resection of the prostate and combined transurethral resection and vaporization of the prostate as a therapeutic alternative in men with benign prostatic hyperplasia.
    Küpeli S; Yilmaz E; Soygür T; Budak M
    J Endourol; 2001 Apr; 15(3):317-21. PubMed ID: 11339401
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy and safety of tamsulosin hydrochloride 0.2 mg and combination of tamsulosin hydrochloride 0.2 mg plus solifenacin succinate 5 mg after transurethral resection of the prostate: a prospective, randomized controlled trial.
    Shin YS; Zhang LT; You JH; Choi IS; Zhao C; Park JK
    Clin Interv Aging; 2016; 11():1301-1307. PubMed ID: 27698559
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oncological and safety profiles in patients undergoing simultaneous transurethral resection (TUR) of bladder tumour and TUR of the prostate.
    Laukhtina E; Moschini M; Krajewski W; Teoh JY; Ploussard G; Soria F; Roghmann F; Muenker MA; Roumiguie M; Alvarez-Maestro M; Misrai V; Antonelli A; Tafuri A; Simone G; Mastroianni R; Zhao H; Rahota RG; D'Andrea D; Mori K; Albisinni S; Karakiewicz PI; Fajkovic H; Enikeev D; Montorsi F; Shariat SF; Pradere B;
    BJU Int; 2023 May; 131(5):571-580. PubMed ID: 36134575
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bipolar transurethral enucleation and resection of the prostate versus bipolar resection of the prostate for prostates larger than 60gr: A retrospective study at a single academic tertiary care center.
    Wei Y; Xu N; Chen SH; Li XD; Zheng QS; Lin YZ; Xue XY
    Int Braz J Urol; 2016; 42(4):747-56. PubMed ID: 27564286
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Usage of GreenLight HPS 180-W laser vaporisation for treatment of benign prostatic hyperplasia.
    Jovanović M; Džamić Z; Aćimović M; Kajmaković B; Pejčić T
    Acta Chir Iugosl; 2014; 61(1):57-61. PubMed ID: 25782227
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Does simultaneous transurethral resection of bladder tumor and prostate affect the recurrence of bladder tumor? A meta-analysis.
    Luo S; Lin Y; Zhang W
    J Endourol; 2011 Feb; 25(2):291-6. PubMed ID: 20977373
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of simultaneous transurethral resection of prostate and solitary bladder tumors smaller than 3 cm on oncologic results.
    Ugurlu O; Gonulalan U; Adsan O; Kosan M; Oztekin V; Cetinkaya M
    Urology; 2007 Jul; 70(1):55-9. PubMed ID: 17656208
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synchronous transurethral cystolitholapaxy and TURP reveals better results than transurethral cystolitholapaxy plus medical therapy for BPH: a randomized prospective study on 100 patients with concomitant urinary bladder stone(s) and BPH.
    Hasan AM; AbdelRazek M; Ali AF; Alsaghier OM; Ahmed AA; Alsaghier GA
    World J Urol; 2022 Feb; 40(2):483-487. PubMed ID: 34807286
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transurethral resection of the prostate in kidney transplant recipients: urological and renal functional outcomes at long-term follow-up.
    Volpe A; Billia M; Quaglia M; Vidali M; Marchioro G; Ceratti G; Sogni F; De Lorenzis E; De Angelis P; Airoldi A; Stratta P; Terrone C
    BJU Int; 2013 Aug; 112(3):386-93. PubMed ID: 23496755
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Transurethral plasmakinetic enucleation of the prostate for benign prostatic hyperplasia].
    Sheng XJ; Chen JH; Wang WM; Kong L; Zhang L; Yu YJ; Wu Y; Qi J
    Zhonghua Nan Ke Xue; 2011 May; 17(5):440-3. PubMed ID: 21837956
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A prospective randomized comparison of transurethral resection to visual laser ablation of the prostate for the treatment of benign prostatic hyperplasia.
    Cowles RS; Kabalin JN; Childs S; Lepor H; Dixon C; Stein B; Zabbo A
    Urology; 1995 Aug; 46(2):155-60. PubMed ID: 7542818
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The recurrence and progression risk after simultaneous endoscopic surgery of urothelial bladder tumour and benign prostatic hyperplasia: a systematic review and meta-analysis.
    Sari Motlagh R; Mori K; Miura N; Quhal F; Aydh A; Laukhtina E; Pradere B; Karakiewicz PI; Enikeev DV; Deuker M; Shariat SF
    BJU Int; 2021 Feb; 127(2):143-152. PubMed ID: 32564458
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.